Platform comparison
Cypris vs PatSnap
Cypris and PatSnap are both AI-native intelligence platforms that sit over patents and scientific literature, and buyers often weigh them side by side for R&D and competitive intelligence. They diverge on data scope, how results are delivered, and how much pricing each puts in the open. Here is a neutral look at how the two compare.
The short version
Cypris and PatSnap are both AI-native platforms over patents and scientific literature, but they lean in different directions. Cypris pairs a broad semantic-search surface (patents, papers, grants, clinical trials, and news) with an optional human research-brief service, while PatSnap centers on a deep proprietary IP corpus with chemical and biosequence depth, driven by task-specific AI agents inside regulated verticals.
Choose Cypris if
you want a wide AI-first discovery surface spanning patents, papers, grants, clinical trials, and news, with the option to layer expert-prepared research briefs on top of the platform.
Choose PatSnap if
you need deep IP and chemical or biosequence depth for regulated verticals like pharma, life sciences, and materials, with task-specific AI agents and a transparent self-serve entry point.
Feature comparison
| Capability | Cypris | PatSnap |
|---|---|---|
| Coverage | Patents, papers, grants, news | Patents, papers, chemical/biosequence |
| Source discovery | User defines queries/domains | User defines queries/filters |
| Output | AI search + analyst briefs | Agent answers, reports, search lists |
| Effort to operate | IP-savvy users, queries needed | Built for trained IP analysts |
| Monitoring | Agentic monitoring, user-defined | Continuous, user-configured alerts |
| Source traceability | Full citations, verifiable | Hover-to-reveal linked references |
| AI approach | AI-native, multi-model ontology | AI-native (Eureka agents) |
| Languages | Multilingual corpus, output unclear | Multilingual UI, translates sources |
| Specialist depth | Deep patent/IP modules | Deep IP corpus, vertical modules |
How they compare, point by point
Data scope
Cypris
A broad discovery mix spanning patents, scientific papers, grants, clinical trials, and tracked news sources in one semantic-search interface, with vendor-reported coverage in the hundreds of millions of data points.
PatSnap
A deep proprietary corpus weighted toward IP, including global patents, scientific literature, litigation, and specialist chemical-structure and biosequence data across regulated verticals.
Output style
Cypris
AI semantic search and landscaping results that the user explores, with an optional human Research Brief service that delivers bespoke, expert-prepared competitive-intelligence reports on top of the platform.
PatSnap
Task-specific AI agents that return answers, reports, and search lists on demand, with hover-to-reveal linked references the analyst reads and interprets.
Who operates it
Cypris
Built as a search-and-discovery surface where the user defines queries and domains, workable for IP-savvy users though it still expects someone comfortable framing searches.
PatSnap
Built for trained patent and IP analysts who drive searches and assemble analytics, assuming a dedicated researcher in the workflow.
Monitoring model
Cypris
Agentic monitoring that runs continuously against a thesis the user defines, with digest updates, so the user specifies what to watch rather than relying on per-vertical auto-discovery.
PatSnap
Continuous, user-configured alerts tied to saved searches and filters, keeping a defined watch running once an analyst sets it up.
Pricing transparency
Cypris
Custom and contact-vendor only, with a free trial as the entry point but no published subscription tiers or figures.
PatSnap
A two-tier model: the self-serve Eureka line publishes prices (from $100/mo, with a free Basic tier), while the enterprise Analytics platform is quote-only.
Origin and regional fit
Cypris
A US-based platform (HQ New York City) with a multilingual source corpus, though the language its conclusions are delivered in is not clearly stated.
PatSnap
Founded in Singapore with a dual Singapore and London presence, its interface ships in a fixed set of languages and it machine-translates source patents for analysts to interpret.
Strengths and best fit
Cypris
- Massive unified data coverage across patents, scientific papers, grants, clinical trials, and tracked news sources, all in a single semantic-search interface.
- Strong enterprise credibility, with marquee customers and official AI partnerships behind the platform.
- A hybrid model that pairs the AI platform with expert-prepared analyst Research Briefs for bespoke competitive-intelligence work.
- Mature feature depth for IP and R&D power users, including freedom-to-operate assessments, competitive landscaping, and prior-art search.
PatSnap
- A deep proprietary data moat: billions of structured data points across global patents, scientific literature, litigation, and chemical and biosequence data in 100+ countries.
- A large, credible incumbent: a 2021 unicorn with more than 10,000 customers worldwide (PatSnap markets 18,000+ innovators), including major law firms, pharma, and high-tech enterprises, and strong brand trust in IP procurement.
- Deep domain specialization: dedicated modules and AI agents for IP, engineering and R&D, life sciences, materials science, plus biosequence and chemical-structure search for regulated verticals.
- A genuinely AI-native repositioning with task-specific Eureka agents (novelty and freedom-to-operate search, patent drafting, office-action response), plus design-risk screening, not a legacy tool with AI bolted on.
Pricing
Cypris
UnverifiedCustom, contact-vendor pricing only. A free trial is offered as the entry point, but there is no free version and no published subscription tiers or figures. Seat-based enterprise pricing is the likely model.
View pricing sourcePatSnap
Two-tier model. The self-serve Eureka line publishes concrete prices (Basic free, R&D Pro from $100/mo, specialist tiers up to $400/mo). The traditional Analytics and enterprise platform is quote-only, with no public rate and widely varying third-party estimates.
View pricing sourceThe verdict
Cypris and PatSnap are both credible AI-native platforms, and the better choice depends on the job. Cypris fits teams that want a broad discovery surface across patents, papers, grants, clinical trials, and news, with the option to add expert-prepared research briefs when they need a finished report. PatSnap fits teams that need deep IP plus chemical and biosequence depth in regulated verticals, with task-specific agents and a transparent self-serve on-ramp through its Eureka line. Both expect someone comfortable driving searches and reading results, with PatSnap leaning more toward the trained IP analyst. If you just want ready-made, scored conclusions delivered in your own language, with the continuous watch run for you, Wicely is a modern option worth a look, on its own or alongside either platform.
Frequently asked questions
- What is the difference between Cypris and PatSnap?
- Cypris is a US-based AI R&D and innovation-intelligence platform offering broad semantic search across patents, papers, grants, clinical trials, and news, with an optional human research-brief service. PatSnap is an AI-native IP and R&D platform built around a deep proprietary patent corpus with chemical and biosequence depth, driven by task-specific AI agents. Cypris leans toward wide discovery, while PatSnap leans toward deep IP specialization in regulated verticals.
- Is Cypris or PatSnap better for chemical and life-sciences research?
- PatSnap has the edge in regulated verticals like pharma, life sciences, and materials, with dedicated chemical-structure and biosequence search and vertical modules. Cypris covers scientific papers and clinical trials broadly but does not market the same specialist chemical and biosequence depth. If your work is structure- or sequence-driven, PatSnap is the more specialized fit.
- How do Cypris and PatSnap pricing compare?
- Cypris is custom and contact-vendor only, with a free trial but no published tiers or figures. PatSnap uses a two-tier model: its self-serve Eureka line publishes prices from $100 a month with a free Basic tier, while its enterprise Analytics platform is quote-only. PatSnap is the more transparent option for a small team that wants to start without a sales conversation.
- Do Cypris and PatSnap require a trained analyst to operate?
- Both are search-and-discovery tools where the user defines queries and interprets results. Cypris is workable for IP-savvy users but still expects someone comfortable framing searches, and PatSnap is built more explicitly for trained patent and IP analysts. Neither does the filtering and synthesis for you, so weigh how much capacity your team has to operate either platform.
- Do Cypris and PatSnap offer continuous monitoring?
- Yes, both do, with different models. Cypris runs agentic monitoring against a thesis the user defines, sending digest updates. PatSnap offers continuous, user-configured alerts tied to saved searches and filters. In both cases the user defines what to watch rather than relying on automatic per-vertical source discovery.
Still weighing your options?
This is a one-to-one comparison. If you are still surveying the field, it is worth seeing how the other tools stack up before you decide.
See Wicely in action
Real public reports that show the kind of scored, business-line intelligence Wicely produces.
Published May 18, 2026
Marine Electric Propulsion Technology Report H1 2026
Patent trends, research signals, and competitive moves in electric marine propulsion - report by Wicely for R&D and innovation leaders in boat manufacturing.
Published May 13, 2026
Sustainable Ingredients & Product Reformulation, H1 2026
Explore the H1 2026 patent landscape, research trends, and emerging players shaping sustainable ingredients and product reformulation for food innovation.
Published May 13, 2026
Connected Equipment & Predictive Maintenance, H1 2026
Explore the H1 2026 patent landscape, research trends, and emerging players shaping edge-to-cloud predictive maintenance for connected industrial equipment.
See Wicely on Your Own Business Line
Book a demo and we'll prepare a Business Line Report on your actual products: scored, sourced conclusions, not a generic example. See the output for yourself before you commit.
Book a demoSimple, usage-based pricing - no per-seat licenses. See pricing
Wicely monitors patents, research papers, and industry news across your product lines - and delivers tailored conclusions specific to your business. Not data lists. Conclusions.
Reports
© 2026 Wicely. All rights reserved.